In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) closed the day trading at $3.23 up 1.57% from the previous closing price of $3.18. In other words, the price has increased by $1.57 from its previous closing price. On the day, 1.17 million shares were traded. ZNTL stock price reached its highest trading level at $3.42 during the session, while it also had its lowest trading level at $3.08.
Ratios:
For a better understanding of ZNTL, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.29 and its Current Ratio is at 7.29. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
On June 20, 2024, UBS Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $28 to $5.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 31 ’24 when Diana Hausman bought 9,888 shares for $2.86 per share.
Vultaggio Vincent sold 1,603 shares of ZNTL for $5,098 on Oct 04 ’24. The Principal Accounting Officer now owns 33,855 shares after completing the transaction at $3.18 per share. On May 31 ’24, another insider, Gallagher Cam, who serves as the President, Interim CFO of the company, sold 9,597 shares for $11.98 each. As a result, the insider received 114,972 and left with 633,680 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZNTL now has a Market Capitalization of 230187248 and an Enterprise Value of -117798760. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.76 while its Price-to-Book (P/B) ratio in mrq is 0.65. Its current Enterprise Value per Revenue stands at -2.904 whereas that against EBITDA is 0.566.
Stock Price History:
Over the past 52 weeks, ZNTL has reached a high of $18.07, while it has fallen to a 52-week low of $2.66. The 50-Day Moving Average of the stock is -5.47%, while the 200-Day Moving Average is calculated to be -58.00%.
Shares Statistics:
Over the past 3-months, ZNTL traded about 2.05M shares per day on average, while over the past 10 days, ZNTL traded about 1386220 shares per day. A total of 70.77M shares are outstanding, with a floating share count of 61.58M. Insiders hold about 13.59% of the company’s shares, while institutions hold 89.79% stake in the company. Shares short for ZNTL as of 1730332800 were 7052724 with a Short Ratio of 3.44, compared to 1727654400 on 8636183. Therefore, it implies a Short% of Shares Outstanding of 7052724 and a Short% of Float of 20.01.
